Marcel Wubbolts (PhD) holds a PhD from the department of Biochemistry, University of Groningen, and was Post-Doctoral research associate and Assistant Professor at the Institute of Biotechnology at the ETH in Zürich. He joined Royal DSM, where he has held several positions. Since October 2011 he has served as Chief Technology Officer, responsible for DSM’s global Science and Technology portfolio. At DSM he is passionate about developing sustainable solutions that address global challenges in health, nutrition, energy and resource scarcity. He is a member of boards and steering committees in several scientific organizations and acts a chair of the board of the consortium for biomedical and biobased materials Chemelot InSciTe in Geleen and as chair of the board of the Biobased Industries Consortium (BIC) in Brussels as part of the Biobased Industries Initiative called BBI, a JTI partnership with the European Commission in the context of Horizon 2020.